This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
S$80.76
Share price
0.00%
Change (1 day)
6.86%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Catalent (CTLT) - Total debt
Total debt on the balance sheet as of September 2024 : S$6.29 Billion
According to Catalent's latest financial reports the company's total debt is S$6.29 Billion. A company’s total debt is the sum of all current and non-current debts.
Catalent - Total debt on balance sheet (from 2013 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | S$6.57 B | 12.12% |
| 2022-06-30 | S$5.86 B | 33.82% |
| 2021-06-30 | S$4.37 B | 3.61% |
| 2020-06-30 | S$4.22 B | 5.66% |
| 2019-06-30 | S$4.00 B | 7.86% |
| 2018-06-30 | S$3.70 B | 29.55% |
| 2017-06-30 | S$2.86 B | 14.23% |
| 2016-06-30 | S$2.50 B | -1.1% |
| 2015-06-30 | S$2.53 B | -25.01% |
| 2014-06-30 | S$3.37 B | -1.06% |
| 2013-06-30 | S$3.41 B | 0.45% |
| 2012-06-30 | S$3.40 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | S$41.09 M | -99.35% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | S$0.42 B | -93.19% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | S$6.89 B | 9.56% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | S$0.28 B | -95.47% | 🇺🇸 USA |